I-BFM-SG: The International BFM Study Group

The I-BFM study group was initiated in 1987 as a “Family Get Together” of the national study groups of Austria (BFM-A), Germany (BFM-G), France/Belgium (EORTC-CLG), Italy (AIEOP) and the Netherlands (DCLSG) to initially compare Leukemia (ALL) treatment modalities and aiming at developing common standards for diagnosis and treatment.

It is IBFM’s mission to advance the knowledge of childhood cancer biology and to translate this from bench to bedside into more effective treatments.

Our vision is to improve treatments for children diagnosed with hematological malignancies

Our objectives

  • Fostering information exchange among the participating groups, including preliminary results
  • Promoting research projects in childhood leukemias, lymphomas and related disorders, including non-Hodgkin’s lymphomas
  • Supporting prospective randomized clinical trials, using consensus approaches and allowing the participation of other groups
  • Initiating cooperative research projects for a better understanding of pediatric cancers' biology
  • Encouraging a quick and accurate translation of findings from basic to clinical research, and vice versa
  • Achieving a better understanding of very rare hematological malignancies

Our principles

  • Improve lives of children and adolescents with leukemia and lymphoma
  • Better understand and translate research findings into better cures
  • Foster information exchange among dedicated research groups
  • Make clinical research the key to better and safer treatments

Sub content